课题基金 / 基金详情

CHAnging Rare disorders of LysInE metabolism

CHAnging Rare disorders of LysInE metabolism
改变赖氨酸代谢的罕见疾病
批准号:
431267
负责人:
Leavitt Blair R
金额:
$32.78万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2020
资助国家:
加拿大
项目状态:
已结题
起止时间:
2020-06-01 至 2023-06-01

项目摘要

项目成果

Leavitt Blair R的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Rare inborn errors of lysine metabolism such as pyridoxine-dependent epilepsy (PDE) and glutaric aciduria type 1 (GA1) cause debilitating, often progressive neurologic symptoms with chronic care dependency. Medical needs are unmet as current dietary thera
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Lipid Nanoparticle-Mediated Delivery of CRISPR/Cas9 Gene Editing for Neurological Disorders.
  • 批准号:
    462295
  • 项目类别:
    Operating Grants
  • 资助金额:
    $55.45万
  • 财政年份:
    2022
  • 负责人:
    Leavitt Blair R
  • 依托单位:
Lipid Nanoparticle-Mediated Delivery of CRISPR/Cas9 Gene Editing for Neurological Disorders.
  • 批准号:
    456004
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2021
  • 负责人:
    Leavitt Blair R
  • 依托单位:
Characterization and treatment of a novel conditional mouse model of pyridoxine-dependent epileptic encephalopathy caused by antiquitin mutations.
  • 批准号:
    419183
  • 项目类别:
    Operating Grants
  • 资助金额:
    $44.58万
  • 财政年份:
    2020
  • 负责人:
    Leavitt Blair R
  • 依托单位:
Development, characterization and treatment of a novel conditional mouse model of pyridoxine-dependent epileptic encephalopathy caused by antiquitin mutations.
  • 批准号:
    387291
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2018
  • 负责人:
    Leavitt Blair R
  • 依托单位:
海外基金